HIK.L

Hikma Pharmaceuticals PLC

Ten-year history of valuation, safety, growth and profitability, with percentile bands against HIK.L’s own range.

Snapshot

P/E

4.8×

Yield

4.1%

P83

FCF payout

69.8%

P40

Net debt / EBITDA

3.56

P67

DGR 5y

11.1%

P57

ROIC

6.0%

P32

Value

Is the share cheap or dear by its own history?

HIK.L is historically cheap. P/E at P8 (4.8x); yield at P83 (4.1%).

Safety

Can the business comfortably cover the dividend?

FCF payout sits at P40 (70%) of its history. Leverage (Net Debt/EBITDA) at P67 (3.56); interest cover at P33 (6.92).

Growth

Is the dividend and the cash behind it still growing?

5-year dividend growth at P57 (11%) of its 10y range. FCF growth P0 (-40%); ROIC P32 (6%).

Profitability

Is the engine getting better or worse at making money?

Gross margin at P0 (42%) of its history. Operating margin P29 (18%); net margin P76 (11%).

Forecast your income with the HIK.L dividend calculator

Free account

Sign up free to look up 10 stocks a day.

Anonymous lookups are capped at three a day. A free account bumps that to ten, and your counter resets at midnight UK time.

Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.